Clinical outcomes, serum IgG changes, and follow-up observations in the treatment of anti-AChR antibody-positive generalized myasthenia gravis with Efgartigimod. [PDF]
Fu J +7 more
europepmc +1 more source
Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series. [PDF]
Huang Y +13 more
europepmc +1 more source
Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study. [PDF]
Chuenkongkaew W +6 more
europepmc +1 more source
Immune Checkpoint Inhibitor Overlap Syndrome: Myocarditis, Myositis, and Myasthenia Gravis in a Patient With Metastatic Melanoma. [PDF]
Bennett S +4 more
europepmc +1 more source
Are you weary of illness? Coping and existential positioning in life with myasthenia gravis. [PDF]
Missel M, Witting N, Beck M.
europepmc +1 more source
Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series. [PDF]
Li Y, Yang Y, Zhu Y, Zhu R.
europepmc +1 more source
Morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis. [PDF]
Ă–ztosun G +3 more
europepmc +1 more source
Neurotoxicity of immune checkpoint inhibitors: a retrospective pharmacovigilance study using FAERS database. [PDF]
Cao L, Wang Y, Dai P, Li X.
europepmc +1 more source
Is Isolated Inferior Rectus Weakness a Strong Indicator for Myasthenia Gravis? [PDF]
Butterworth E +3 more
europepmc +1 more source

